George Perry
Chairman of the Scientific Advisory BoardDr. George Perry, Ph.D., M.B.A. had been Member of Alzheimer's Disease Scientific Advisory Board at NervGen Pharma Corp. since January 2021 until September 2026. He has served as an Acting Chief Scientific officer at Neurotez, Inc. since 2010. Dr. Perry has served as Dean of the College of Sciences and Professor of Biology at The University of Texas at San Antonio since 2006. Dr. Perry holds the Semmes Foundation Distinguished University Chair in Neurobiology at The University of Texas at San Antonio. Dr. Perry has been a Strong Advocate for greater diversity in ideas to move the field forward. He had been an Independent Director of TAO Synergies Inc. (formerly known as Synaptogenix, Inc.) (formerly, Neurotrope Bioscience, Inc.) since December 12, 2017 until September 30, 2021. He serves as the Chairman of the Scientific Advisory Board at TAO Synergies Inc. (formerly known as Synaptogenix, Inc.) (formerly, Neurotrope Bioscience, Inc.) since September 30, 2021. He served as Principal Investigator of Panacea Pharmaceuticals, Inc. Dr. Perry joined the faculty of Case Western Reserve University in 1982 as an Assistant Professor and served as a Professor in the Departments of Pathology and Neurosciences and as Interim-Chair of the Department of Pathology. He served as a Director of Neurotrope, Inc. since December 12, 2017. He served as a Director at Neurotez, Inc. since 2008. He had been a Member of the Scientific Advisory Board at Phoenix Biotechnology, Inc. since February 13, 2017 until 2020. Dr. Perry's studies are focused on the mechanism of formation and physiological consequences of the cytopathology of Alzheimer disease. He is distinguished as one of the top Alzheimer disease researchers with over 600 publications, one of the top 100 most-cited scientists in Neuroscience & Behavior and one of the top 25 scientists in free radical research. Dr. Perry is recognized in the field of Alzheimer?s research, where he has studied amyloidosis, oxidative stress, cytoskeleton, metal homeostasis, cell cycle reentry and mitochondria. He has been cited over 26,000 times and is recognized as an ISI highly cited researcher. He is editor for numerous journals and is editor-in-chief for the Journal of Alzheimers Disease. He was President of the American Association of Neuropathologists and the Southwestern and Rocky Mountain Division of the American Association for the Advancement of Science. He is a Fellow of the American Association for the Advancement of Sciences in 1998, Texas Academy of Science, the Microscopy Society of America, won the Denham Harman Lifetime Achievement Award (discoverer of the Free Radical Theory of Aging) from the American Association for Aging and holds the Zenith Award from the Alzheimer Association. Additionally, he is an internationally known invited lecturer and has numerous papers, presentations and publications. He is a Member of the Dana Alliance for Brain Initiatives and a Fulbright Senior Specialist. Dr. Perry has received a number of awards for his research in the Alzheimer's disease space, including the Senior Investigator Award from the College of Geriatric Psychoneuropharmacology and the Zenith and Temple Awards from the Alzheimer's Association. Dr. Perry obtained his Bachelor of Arts in Zoology with high honors from the University of California at Santa Barbara in 1974 and completed his Ph.D. in Marine Biology from the Scripps Institution of Oceanography, University of California, San Diego in 1979. He completed his postdoctoral fellowship in the Department of Cell Biology at Baylor College of Medicine.
Positions
- Company NameTAO Synergies Inc.Stock CodeTAOXPositionChairman of the Scientific Advisory BoardColleagues
- JNJoshua N. SilvermanExecutive Chairman of the Board
- RWRobert WeinsteinCFO, Executive VP, Treasurer & Secretary
- AJAlan J. TuchmanChief Medical Officer
- WSWilliam S. SingerIndependent Vice-Chairman of the Board
- BTBruce T. BernsteinIndependent Vice-Chairman of the Board
- PCPaul ColemanMember of Scientific Advisory Board
